Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 2
1984 1
1985 1
1986 2
1987 2
1988 1
1989 4
1990 5
1991 4
1992 7
1993 5
1994 13
1995 6
1996 8
1997 19
1998 22
1999 21
2000 19
2001 19
2002 44
2003 58
2004 43
2005 46
2006 86
2007 89
2008 136
2009 136
2010 167
2011 220
2012 230
2013 273
2014 312
2015 350
2016 406
2017 469
2018 527
2019 526
2020 613
2021 242
Text availability
Article attribute
Article type
Publication date

Search Results

4,605 results
Results by year
Filters applied: . Clear all
Page 1
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L, Gao G, Hu X, Zhang Y, Tong Z, Huang W, Liu WJ, Wu G, Zhang B, Wang L, Qi J, Feng H, Wang FS, Wang Q, Gao GF, Yuan Z, Yan J. Shi R, et al. Among authors: qi j. Nature. 2020 Aug;584(7819):120-124. doi: 10.1038/s41586-020-2381-y. Epub 2020 May 26. Nature. 2020. PMID: 32454512
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M, Li Y, Cheng H, Yuan Y, Zhang W, Ke C, Wong G, Qi J, Qin C, Yan J, Gao GF. Dai L, et al. Among authors: qi j. Cell. 2020 Aug 6;182(3):722-733.e11. doi: 10.1016/j.cell.2020.06.035. Epub 2020 Jun 28. Cell. 2020. PMID: 32645327 Free PMC article.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanović B, Murphy K, Wang B, Qiu X, Endress JE, Reyes J, Lim K, Font-Tello A, Syamala S, Xiao T, Reddy Chilamakuri CS, Papachristou EK, D'Santos C, Anand J, Hinohara K, Li W, McDonald TO, Luoma A, Modiste RJ, Nguyen QD, Michel B, Cejas P, Kadoch C, Jaffe JD, Wucherpfennig KW, Qi J, Liu XS, Long H, Brown M, Carroll JS, Brugge JS, Bradner J, Michor F, Polyak K. Shu S, et al. Among authors: qi j. Mol Cell. 2020 Jun 18;78(6):1096-1113.e8. doi: 10.1016/j.molcel.2020.04.027. Epub 2020 May 15. Mol Cell. 2020. PMID: 32416067
Using Chemical Epigenetics to Target Cancer.
Wimalasena VK, Wang T, Sigua LH, Durbin AD, Qi J. Wimalasena VK, et al. Among authors: qi j. Mol Cell. 2020 Jun 18;78(6):1086-1095. doi: 10.1016/j.molcel.2020.04.023. Epub 2020 May 13. Mol Cell. 2020. PMID: 32407673 Review.
Advances in Developing CAR T-Cell Therapy for HIV Cure.
Qi J, Ding C, Jiang X, Gao Y. Qi J, et al. Front Immunol. 2020 Mar 10;11:361. doi: 10.3389/fimmu.2020.00361. eCollection 2020. Front Immunol. 2020. PMID: 32210965 Free PMC article. Review.
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer.
Ge JY, Shu S, Kwon M, Jovanović B, Murphy K, Gulvady A, Fassl A, Trinh A, Kuang Y, Heavey GA, Luoma A, Paweletz C, Thorner AR, Wucherpfennig KW, Qi J, Brown M, Sicinski P, McDonald TO, Pellman D, Michor F, Polyak K. Ge JY, et al. Among authors: qi j. Nat Commun. 2020 May 11;11(1):2350. doi: 10.1038/s41467-020-16170-3. Nat Commun. 2020. PMID: 32393766 Free PMC article.
4,605 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page